Stocksigma LogoStocksigma Logo

Cohance Lifesciences Appoints Abhimanyu Ojha as Chief Financial Officer

Cohance Lifesciences Limited (formerly Suven Pharmaceuticals) has approved the appointment of Abhimanyu Ojha as Chief Financial Officer and Key Managerial

Cohance Lifesciences Appoints Abhimanyu Ojha as Chief Financial Officer

Cohance Lifesciences Ltd 路 Change in Management 路 10 Oct 2026, 1:54 am

Cohance Lifesciences Appoints Abhimanyu Ojha as Chief Financial Officer Cohance Lifesciences Limited (formerly Suven Pharmaceuticals) has approved the appointment of Abhimanyu Ojha as Chief Financial Officer and Key Managerial Personnel, effective 12th Oct'26. Ojha brings over two decades of pharma and healthcare leadership experience, having previously served as Global CFO & President Finance at Intas Pharmaceuticals, along with senior leadership roles at Viatris, Sun Pharmaceuticals, and Ranbaxy Laboratories. He will also join the authorized Key Managerial Personnel panel alongside Chairman & Group CEO Umang Vohra to determine and disclose material events.

Original exchange filing (PDF)

More announcements from Cohance Lifesciences Ltd

All Cohance Lifesciences Ltd announcements